Dual Modulation of Innate and Adaptive Immunity with Thymosin Alpha-1 (Ta1)

Journal Context: International Immunopharmacology / PubMed | Identifiers: DOI: 10.1016/j.intimp.2020.106824 / PMID: 32711314

Principal Investigators: Matteucci, C., Minutolo, A., Politi, C., Garaci, E., et al. (Department of Experimental Medicine, University of Rome Tor Vergata, Italy)

Methodology: In vitro and ex vivo tracking of human primary dendritic cells, macrophages, and T-lymphocyte arrays exposed to severe viral pathogen profiles. Experimental groups were treated with standardized gradients of synthetic $\text{T}\alpha1$ to chart the transcription velocities of cell-surface receptors and downstream signal proteins.

Key Findings: The study demonstrated that $\text{T}\alpha1$ acts as a smart immune regulator. It directly upregulated the activation of Toll-like Receptor 9 (TLR9) and TLR2, signaling dendritic cells to rapidly expand the pool of cancer-fighting Natural Killer (NK) cells and Cytotoxic T-lymphocytes ($\text{CD8}^+$). Simultaneously, in hyper-inflamed environments, $\text{T}\alpha1$ selectively boosted the generation of Regulatory T-cells ($\text{T}_{\text{reg}}$) and stimulated the release of Interleukin-10 ($\text{IL}-10$). This dual action successfully suppressed the expression of tissue-destroying inflammatory switches ($\text{TNF}-\alpha$ and $\text{IL}-6$), proving its capacity to resolve severe inflammatory cycles without causing overactive immune responses.